NCT02161107

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Parallel-Group Study to Assess the Safety and Tolerability of Grass-SPIRE in Subjects With Asthma and Grass-Induced Rhinoconjunctivitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: Circassia Limited · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether it is safe to administer Grass-SPIRE to subjects suffering from both grass allergy and asthma

Conditions

• Seasonal Allergic Rhinitis
• Asthma

Interventions

Type	Name	Description
BIOLOGICAL	Grass-SPIRE	Intradermal injection
BIOLOGICAL	Placebo	Intradermal injection

Timeline

• Start date: 2014-04-01
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2014-06-11
• Last updated: 2015-03-24

Locations

5 sites across 1 country: Canada